Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.1000 (-2.76%) ($14.0000 - $14.7500) on Tue. Oct. 25, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.81% (three month average) | RSI | 23 | Latest Price | $14.1000(-2.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -1.905% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-9%) IPO(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.905% (StdDev 3.81%) | Hourly BBV | 0 () | Intraday Trend | -3.1% | | | |
|
1 - 5 Day Possible Target | $-9.47(-167.16%) | Resistance Level | $17.22 | 5 Day Moving Average | $14.74(-4.34%) | 10 Day Moving Average | $15.33(-8.02%) | 20 Day Moving Average | $17.22(-18.12%) | To recent high | -43.3% | To recent low | 0% | Market Cap | $1.048b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |